SynthesisFrontiers in immunology2026

Infection risk associated with teclistamab in relapsed/refractory multiple myeloma: a systematic review and meta-analysis of clinical trial and real-world evidence.

Zeng-Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.